510(k) device
SmartAdjust Technology
Insulet Corporation · Interoperable Automated Glycemic Controller (QJI, Class II) · First FDA decision Jan 27, 2022, newest Aug 26, 2024Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
2
Naming "SmartAdjust Technology"
MAUDE reports
0
Brand "SmartAdjust Technology", since 2015
PubMed studies
0
Mentioning "SmartAdjust Technology"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SmartAdjust Technology
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- SmartAdjust Technology510(k)
K241777 · Decided Aug 26, 2024 · 67 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
K232741 · Decided May 29, 2024 · 265 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
K220394 · Decided Aug 19, 2022 · 189 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SmartAdjust Technology", any status and sponsor, newest update first.
- The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMsActive, not recruiting
Universitaire Ziekenhuizen KU LeuvenAcademic, hospital or other
NCT04414280 · 1,600 participants (planned) · Start Mar 12, 2020 · Primary completion Apr 2028
Device: Medtronic MiniMed 670G; Medtronic MiniMed 780G and 2 more · For: Diabetes Mellitus, Type 1
Sites: Leuven, Belgium; Aalst, Belgium; Antwerp, Belgium · 38 sites in all
- Automated Insulin Delivery for Inpatients With DysglycemiaPivotal-lookingCompleted
Emory UniversityAcademic, hospital or other
NCT06418880 · 130 participants · Start Jan 22, 2025 · Primary completion Oct 31, 2025
Device: AID system with Remote Real-Time CGM · For: Type 1 Diabetes; Type 2 Diabetes
Sites: Stanford, California; Atlanta, Georgia; Charlottesville, Virginia
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SmartAdjust Technology", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QJI
5,524 reports: 3,680 malfunction, 1,836 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SmartAdjust Technology"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJI.
- SmartGuard TechnologyMedtronic MiniMed · 510(k) 2026
- iLet Dosing Decision SoftwareBeta Bionics, Inc. · 510(k) 2026
- Control-IQ+ technologyTandem Diabetes Care, Inc. · 510(k) 2026
- Control-IQ TechnologyTandem Diabetes Care, Inc. · De Novo 2023
- twiist Loop AlgorithmDeka Research and Development Corp. · 510(k) 2026
- iOS CamAPS FXCamDiab · 510(k) 2026
- Omnipod 6 algorithmInsulet Corporation · 510(k) 2026
- DBLG2Diabeloop · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.